Validation of a Lung Cancer Plasma Reflex Test Using Epigenetic Biomarker for Cancer Detection

Project Information

proLungPlasma

Grant agreement ID: 672680

DOI

10.3030/672680

Project closed

EC signature date 2 June 2015

Start date 1 July 2015

End date 31 December 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 2 772 527,50

EU contribution

€ 2 772 527,50

Coordinated by

EPIGENOMICS AG
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Registration Documents

Finalisation of Registration documents (for European registration according to new IVD).

Publications

Peer reviewed articles (1)

Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease

Author(s): Gunter Weiss, Anne Schlegel, Denise Kottwitz, Thomas König, Reimo Tetzner
Published in: Journal of Thoracic Oncology, Issue 12/1, 2017, Page(s) 77-84, ISSN 1556-0864
Publisher: Lippincott Williams & Wilkins Ltd.
DOI: 10.1016/j.jtho.2016.08.123